BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 33706239)

  • 1. Opportunity knocks for uncovering the new function of an understudied nucleosome remodeling complex member, the bromodomain PHD finger transcription factor, BPTF.
    Zahid H; Olson NM; Pomerantz WCK
    Curr Opin Chem Biol; 2021 Aug; 63():57-67. PubMed ID: 33706239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New inhibitors for the BPTF bromodomain enabled by structural biology and biophysical assay development.
    Ycas PD; Zahid H; Chan A; Olson NM; Johnson JA; Talluri SK; Schonbrunn E; Pomerantz WCK
    Org Biomol Chem; 2020 Jul; 18(27):5174-5182. PubMed ID: 32588860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Design Rules for Developing Potent Cell-Active Inhibitors of the Nucleosome Remodeling Factor (NURF) via BPTF Bromodomain Inhibition.
    Zahid H; Buchholz CR; Singh M; Ciccone MF; Chan A; Nithianantham S; Shi K; Aihara H; Fischer M; Schönbrunn E; Dos Santos CO; Landry JW; Pomerantz WCK
    J Med Chem; 2021 Sep; 64(18):13902-13917. PubMed ID: 34515477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis for site-specific read-out of histone H3K4me3 by the BPTF PHD finger of NURF.
    Li H; Ilin S; Wang W; Duncan EM; Wysocka J; Allis CD; Patel DJ
    Nature; 2006 Jul; 442(7098):91-5. PubMed ID: 16728978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of selective BPTF bromodomain inhibitors by screening and structure-based optimization.
    Xiong L; Mao X; Guo Y; Zhou Y; Chen M; Chen P; Yang S; Li L
    Biochem Biophys Res Commun; 2021 Mar; 545():125-131. PubMed ID: 33548625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compound C620-0696, a new potent inhibitor targeting BPTF, the chromatin-remodeling factor in non-small-cell lung cancer.
    Xu J; Wang Q; Leung ELH; Li Y; Fan X; Wu Q; Yao X; Liu L
    Front Med; 2020 Feb; 14(1):60-67. PubMed ID: 31104301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autophagy-Dependent Sensitization of Triple-Negative Breast Cancer Models to Topoisomerase II Poisons by Inhibition of the Nucleosome Remodeling Factor.
    Tyutyunyk-Massey L; Sun Y; Dao N; Ngo H; Dammalapati M; Vaidyanathan A; Singh M; Haqqani S; Haueis J; Finnegan R; Deng X; Kirberger SE; Bos PD; Bandyopadhyay D; Pomerantz WCK; Pommier Y; Gewirtz DA; Landry JW
    Mol Cancer Res; 2021 Aug; 19(8):1338-1349. PubMed ID: 33811160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of NVS-BPTF-1 and evaluation of its biological activity.
    Mélin L; Calosing C; Kharenko OA; Hansen HC; Gagnon A
    Bioorg Med Chem Lett; 2021 Sep; 47():128208. PubMed ID: 34146702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling.
    Wysocka J; Swigut T; Xiao H; Milne TA; Kwon SY; Landry J; Kauer M; Tackett AJ; Chait BT; Badenhorst P; Wu C; Allis CD
    Nature; 2006 Jul; 442(7098):86-90. PubMed ID: 16728976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromatin remodeling complex NURF regulates thymocyte maturation.
    Landry JW; Banerjee S; Taylor B; Aplan PD; Singer A; Wu C
    Genes Dev; 2011 Feb; 25(3):275-86. PubMed ID: 21289071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Essential role of chromatin remodeling protein Bptf in early mouse embryos and embryonic stem cells.
    Landry J; Sharov AA; Piao Y; Sharova LV; Xiao H; Southon E; Matta J; Tessarollo L; Zhang YE; Ko MS; Kuehn MR; Yamaguchi TP; Wu C
    PLoS Genet; 2008 Oct; 4(10):e1000241. PubMed ID: 18974875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of bromodomain PHD finger transcription factor in ovarian cancer and its critical role for cancer cell proliferation and survival.
    Miao J; Zhang M; Huang X; Xu L; Tang R; Wang H; Han S
    Biochem Cell Biol; 2021 Jun; 99(3):304-312. PubMed ID: 32985220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Chromatin Remodeler BPTF Activates a Stemness Gene-Expression Program Essential for the Maintenance of Adult Hematopoietic Stem Cells.
    Xu B; Cai L; Butler JM; Chen D; Lu X; Allison DF; Lu R; Rafii S; Parker JS; Zheng D; Wang GG
    Stem Cell Reports; 2018 Mar; 10(3):675-683. PubMed ID: 29456179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haploinsufficiency of the Chromatin Remodeler BPTF Causes Syndromic Developmental and Speech Delay, Postnatal Microcephaly, and Dysmorphic Features.
    Stankiewicz P; Khan TN; Szafranski P; Slattery L; Streff H; Vetrini F; Bernstein JA; Brown CW; Rosenfeld JA; Rednam S; Scollon S; Bergstrom KL; Parsons DW; Plon SE; Vieira MW; Quaio CRDC; Baratela WAR; Acosta Guio JC; Armstrong R; Mehta SG; Rump P; Pfundt R; Lewandowski R; Fernandes EM; Shinde DN; Tang S; Hoyer J; Zweier C; Reis A; Bacino CA; Xiao R; Breman AM; Smith JL; ; Katsanis N; Bostwick B; Popp B; Davis EE; Yang Y
    Am J Hum Genet; 2017 Oct; 101(4):503-515. PubMed ID: 28942966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual Screening of BPTF and Brd4 Using Protein-Observed Fluorine NMR Uncovers New Bromodomain Probe Molecules.
    Urick AK; Hawk LM; Cassel MK; Mishra NK; Liu S; Adhikari N; Zhang W; dos Santos CO; Hall JL; Pomerantz WC
    ACS Chem Biol; 2015 Oct; 10(10):2246-56. PubMed ID: 26158404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromodomain inhibition targeting BPTF in the treatment of melanoma and other solid tumors.
    Khan I; Kashani-Sabet M
    Clin Exp Metastasis; 2024 Apr; ():. PubMed ID: 38683257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The conformation of the histone H3 tail inhibits association of the BPTF PHD finger with the nucleosome.
    Morrison EA; Bowerman S; Sylvers KL; Wereszczynski J; Musselman CA
    Elife; 2018 Apr; 7():. PubMed ID: 29648537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of High-Affinity Inhibitors of the BPTF Bromodomain.
    Lu T; Lu H; Duan Z; Wang J; Han J; Xiao S; Chen H; Jiang H; Chen Y; Yang F; Li Q; Chen D; Lin J; Li B; Jiang H; Chen K; Lu W; Lin H; Luo C
    J Med Chem; 2021 Aug; 64(16):12075-12088. PubMed ID: 34375106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bptf determines oncogenic addiction in aggressive B-cell lymphomas.
    Richart L; Felipe I; Delgado P; Andrés MP; Prieto J; Pozo ND; García JF; Piris MA; Ramiro A; Real FX
    Oncogene; 2020 Jun; 39(25):4884-4895. PubMed ID: 32451433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BPTF promotes hepatocellular carcinoma growth by modulating hTERT signaling and cancer stem cell traits.
    Zhao X; Zheng F; Li Y; Hao J; Tang Z; Tian C; Yang Q; Zhu T; Diao C; Zhang C; Chen M; Hu S; Guo P; Zhang L; Liao Y; Yu W; Chen M; Zou L; Guo W; Deng W
    Redox Biol; 2019 Jan; 20():427-441. PubMed ID: 30419422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.